Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Prenatal neuroinflammation: maternal microbiome contributions and behavioral consequences

Award Number: R01MH129589
ORGANIZATION: NATIONAL INSTITUTE OF MENTAL HEALTH
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 05/01/2022
PERIOD OF PERFORMANCE END DATE: 02/28/2027

Group Awards By:

View Award Description

Prenatal neuroinflammation: maternal microbiome contributions and behavioral consequences - Summary: Prenatal stress is pervasive and negatively impacts both the mother and the developing fetus; offspring bear an increased risk of aberrant neurodevelopment and psychiatric disorders. Indeed, there is a critical window in utero where neurodevelopment is vulnerable to stress-induced alterations in the intrauterine environment, including inflammation; how alterations in the maternal milieu are transmitted to the developing brain, contributing to behavioral alterations, requires scrutinizing. We have established a mouse model of prenatal stress, which in addition to altering maternal and offspring microbiota, induces inflammation in utero, including increases in the chemokine C-C motif chemokine ligand 2 (CCL2), resulting in reduced social behaviors and longstanding neuroinflammation. Furthermore, we have exciting supporting and preliminary data suggesting that normal neurodevelopment is disrupted by prenatal stress in a microbe- and CCL2-dependent manner. As a chemokine, CCL2 has a key role in both attracting myeloid cells and enhancing their inflammatory profile. Within the brain, the myeloid compartment includes microglia, the resident macrophages of the central nervous system; border-associated macrophages (BAMs), which are found in the perivascular space, choroid plexus, and meninges; and circulating monocytes. However, the effects of prenatal stress and CCL2 on the composition of and cytokine production by these subpopulations has yet to be elucidated, and is critical as cytokine signaling is important for homeostatic functions during neurodevelopment, including regulating neuro- and gliogenesis. Therefore, the goal of this R01 is to investigate the relationship between prenatal stress, brain macrophages and monocytes, and social behavior. Our model of prenatal stress will be used to test the highly novel, and integrative hypothesis that, during prenatal stress, there are alterations in the composition of brain macrophages and monocytes in the fetal brain, increasing cytokine production, influencing neurodevelopment. Next, we will determine whether cell-specific elimination of CCL2 production is able to prevent neuroinflammation and subsequent alterations in social behavior. Finally, in an exploratory aim, we will test whether alterations in the maternal microbiome are necessary and sufficient to induce the persistent neuroinflammation and concomitant reduction in social behavior in adult offspring. Our overarching hypothesis is that prenatal stress leads to fetal neuroinflammation that results in long term behavioral abnormalities by altering the composition of macrophages and monocytes in the developing brain and increasing their inflammatory profile, which is driven by disruption of maternal microbes and CCL2. This hypothesis will be tested by pursuing these aims: 1) Determining whether prenatal stress alters the composition of fetal brain macrophages and monocytes 2) Elucidating whether CCL2 drives inflammation in fetal macrophages and monocytes following prenatal stress 3) Determining whether prenatal stress-induced microbiome disruptions drive offspring neuroinflammation and reduced social behaviors.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $545,605 )
2026	2026	OHIO STATE UNIVERSITY, THE	1960 KENNY RD	COLUMBUS	OH	43210	FRANKLIN	USA	Mental Health Research Grants	000	5	3/20/2026	NON-COMPETING CONTINUATION	$545,605
														Subtotal = $545,605

Issue Date FY: 2025 ( Subtotal = $545,605 )
2025	2025	OHIO STATE UNIVERSITY, THE	1960 KENNY RD	COLUMBUS	OH	43210	FRANKLIN	USA	Mental Health Research Grants	000	4	2/13/2025	NON-COMPETING CONTINUATION	$463,764
2025	2025	OHIO STATE UNIVERSITY, THE	1960 KENNY RD	COLUMBUS	OH	43210	FRANKLIN	USA	Mental Health Research Grants	001	4	9/19/2025	NON-COMPETING CONTINUATION	$81,841
														Subtotal = $545,605

Issue Date FY: 2024 ( Subtotal = $544,156 )
2024	2024	OHIO STATE UNIVERSITY, THE	1960 KENNY RD	COLUMBUS	OH	43210	FRANKLIN	USA	Mental Health Research Grants	001	3	8/14/2024	NON-COMPETING CONTINUATION	$54,416
2024	2024	OHIO STATE UNIVERSITY, THE	1960 KENNY RD	COLUMBUS	OH	43210	FRANKLIN	USA	Mental Health Research Grants	000	3	2/16/2024	NON-COMPETING CONTINUATION	$489,740
														Subtotal = $544,156

Issue Date FY: 2023 ( Subtotal = $552,286 )
2023	2023	OHIO STATE UNIVERSITY, THE	1960 KENNY RD	COLUMBUS	OH	43210	FRANKLIN	USA	Mental Health Research Grants	000	2	3/2/2023	NON-COMPETING CONTINUATION	$552,286
														Subtotal = $552,286

Issue Date FY: 2022 ( Subtotal = $567,291 )
2022	2022	OHIO STATE UNIVERSITY, THE	1960 KENNY RD	COLUMBUS	OH	43210	FRANKLIN	USA	Mental Health Research Grants	000	1	4/11/2022	NEW	$567,291
														Subtotal = $567,291

Grand Total All Awards = $2,754,943

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Prenatal neuroinflammation: maternal microbiome contributions and behavioral consequences

Award Number: R01MH129589

ORGANIZATION: NATIONAL INSTITUTE OF MENTAL HEALTH

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 05/01/2022

PERIOD OF PERFORMANCE END DATE: 02/28/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer